AQUEOUS FORMULATIONS OF AN ANTI-CD22 ANTIBODY AND USES THEREOF
A stable pharmaceutical formulation of a therapeutically active anti-CD22 antibody, Suciraslimab (or SM03), for injection. In particular, the formulations comprising, in addition to a suitable amount of the anti-CD22 antibody.The formulations comprise additionally at least one buffering agent, such...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A stable pharmaceutical formulation of a therapeutically active anti-CD22 antibody, Suciraslimab (or SM03), for injection. In particular, the formulations comprising, in addition to a suitable amount of the anti-CD22 antibody.The formulations comprise additionally at least one buffering agent, such as a phosphate buffer and a nonionic surfactant. Methods for preparing such stable formulation and their uses thereof are also provided. |
---|